Weng Chunyue, Nguyen Tung, Shively John E
From the City of Hope Irell & Manella Graduate School of Biological Sciences, Duarte, California 91010 and the Department of Immunology, Beckman Research Institute of City of Hope, Duarte, California 91010.
the Department of Immunology, Beckman Research Institute of City of Hope, Duarte, California 91010.
J Biol Chem. 2016 Aug 5;291(32):16777-86. doi: 10.1074/jbc.M115.710152. Epub 2016 Jun 14.
Lumen formation of breast epithelium is rapidly lost during tumorigenesis along with expression of cell adhesion molecule CEACAM1. CEACAM1 induces lumena in a three-dimensional culture of MCF7/CEACAM1 cells that otherwise fail to form lumena. We hypothesized miRNAs may be involved because >400 genes were up- or down-regulated in MCF7/CEACAM1 cells and miRNAs may modify global expression patterns. Comparative analysis of miRNA expression in MCF7 versus MCF7/CEACAM1 cells revealed two miRNAs significantly down-regulated (hsa-miR-30a-3p by 6.73-fold and hsa-miR-342-5p by 5.68-fold). Location of miR-342 within an intron of the EVL gene, hypermethylated and involved in tumorigenesis, suggested that miR-342 overexpression may block lumen formation. In fact, overexpression of miR-342 in MCF7/CEACAM1 cells significantly blocked lumen formation (p < 0.001). ID4, a dominant-negative inhibitor of basic helix-loop-helix transcription factors, up-regulated in MCF7/CEACAM1 cells, down-regulated in breast cancer, and containing a miR-342 binding site, was tested as a potential target of miR-342. The ratio of ID4 to miR-342 increased from 1:2 in MCF7 cells to 30:1 in MCF7/CEACAM1 cells and a miR-342 inhibitor was able to induce 3'-UTR ID4 reporter activity in MCF7 cells. Because 5-methylcytosine methyltransferase DNMT1 is also a potential target of miR-342, we inhibited miR-342 in MCF7 cells and found DNMT1 was up-regulated with no change in EVL expression, suggesting that miR-342 regulates DNMT1 expression but DNMT1 does not affect the EVL expression in these cells. We conclude that the regulation of lumen formation by miR-342 involves at least two of its known targets, namely ID4 and DNMT1.
在肿瘤发生过程中,乳腺上皮的管腔形成会迅速丧失,同时细胞粘附分子CEACAM1的表达也会丧失。CEACAM1在MCF7/CEACAM1细胞的三维培养中诱导管腔形成,否则这些细胞无法形成管腔。我们推测miRNA可能参与其中,因为在MCF7/CEACAM1细胞中有超过400个基因上调或下调,而miRNA可能会改变整体表达模式。对MCF7细胞和MCF7/CEACAM1细胞中miRNA表达的比较分析显示,有两种miRNA显著下调(hsa-miR-30a-3p下调6.73倍,hsa-miR-342-5p下调5.68倍)。miR-342位于EVL基因的一个内含子内,该内含子发生高甲基化并参与肿瘤发生,这表明miR-342的过表达可能会阻断管腔形成。事实上,在MCF7/CEACAM1细胞中过表达miR-342会显著阻断管腔形成(p < 0.001)。ID4是一种碱性螺旋-环-螺旋转录因子的显性负性抑制剂,在MCF7/CEACAM1细胞中上调,在乳腺癌中下调,并且含有一个miR-342结合位点,被作为miR-342的潜在靶点进行检测。ID4与miR-342的比例从MCF7细胞中的1:2增加到MCF7/CEACAM1细胞中的30:1,并且一种miR-342抑制剂能够在MCF7细胞中诱导3'-UTR ID4报告基因活性。由于5-甲基胞嘧啶甲基转移酶DNMT1也是miR-342的潜在靶点,我们在MCF7细胞中抑制miR-342,发现DNMT1上调,而EVL表达没有变化,这表明miR-342调节DNMT1的表达,但DNMT1在这些细胞中不影响EVL的表达。我们得出结论,miR-342对管腔形成的调节至少涉及其两个已知靶点,即ID4和DNMT1。